KRYS

Krystal Biotech, Inc.

Latest Form 4:Sale$8.2MbyROSSI DINO A (Director) · filed Aug 14, 2026

Krystal Biotech, Inc. (KRYS) has 16 SEC Form 4 filings (148 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Aug 14, 2026.

The most active filer is Director JANNEY DANIEL with 4 filings. Insiders have net sold $61.9M over the trailing 6 months.

  • Industry:Biotechnology
  • CEO:Krish S. Krishnan
  • Employees:275
  • HQ:Pittsburgh, PA, US
  • IPO:2017-09-20

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$87.3M

reported sales (SEC code S)

Unique Insiders

6

in the rolling window

Market Cap

$10.4B

latest known value

Source
ROSSI DINO AFirst in 6 months
Sale$8.2MAug 14SEC ↗
Sale$347KJun 26SEC ↗
Krishnan SumaFirst in 3 months
Sale$7.7MJun 5SEC ↗
Krishnan Krish SFirst in 3 months
Sale$7.7MJun 5SEC ↗
Sale$194KMay 27SEC ↗
Krishnan Krish SFirst in 3 months
Sale$6.6MMar 6SEC ↗
Krishnan SumaFirst in 3 months
Sale$6.6MMar 6SEC ↗
Sale$201KMar 3SEC ↗
Sale$3.3MMar 3SEC ↗
JANNEY DANIELFirst filing
Sale$13.8MFeb 26SEC ↗
JANNEY DANIELFirst filing
Sale$193KFeb 26SEC ↗
JANNEY DANIELFirst filing
Sale$2.1MFeb 26SEC ↗
ROSSI DINO AFirst filing
Sale$5.0MFeb 23SEC ↗
ROMANO KATHRYNFirst filing
Sale$3.4MFeb 11SEC ↗
Krishnan Krish SFirst filing
Sale$11.0MDec 5SEC ↗
Krishnan SumaFirst filing
Sale$11.0MDec 5SEC ↗

Related companies

Krystal Biotech, Inc. is in the Healthcare sector.